Construct Validity of a Continuous Metabolic Syndrome Score in Children

Overview

Journal Diabetol Metab Syndr

Publisher Biomed Central

Specialty Endocrinology

Date 2010 Feb 26

PMID 20181030

Citations 50

Authors

Joey C Eisenmann

Kelly R Laurson

Katrina D Dubose

Bryan K Smith

Joseph E Donnelly

Affiliations

Soon will be listed here.

Abstract

Objective: The primary purpose of this study was to examine the construct validity of a continuous metabolic syndrome score (cMetS) in children. The secondary purpose was to identify a cutpoint value(s) for an adverse cMetS based on receiver operating characteristic (ROC) curve analysis.

Methods: 378 children aged 7 to 9 years were assessed for the metabolic syndrome which was determined by age-modified cutpoints. High-density-lipoprotein cholesterol, triglycerides, the homeostasis assessment model of insulin resistance, mean arterial pressure, and waist circumference were used to create a cMetS for each subject.

Results: About half of the subjects did not possess any risk factors while about 5% possessed the metabolic syndrome. There was a graded relationship between the cMetS and the number of adverse risk factors. The cMetS was lowest in the group with no adverse risk factors (-1.59 +/- 1.76) and highest in those possessing the metabolic syndrome (> or =3 risk factors) (7.05 +/- 2.73). The cutoff level yielding the maximal sensitivity and specificity for predicting the presence of the metabolic syndrome was a cMetS of 3.72 (sensitivity = 100%, specificity = 93.9%, and the area of the curve = 0.978 (0.957-0.990, 95% confidence intervals).

Conclusion: The results demonstrate the construct validity for the cMetS in children. Since there are several drawbacks to identifying a single cut-point value for the cMetS based on this sample, we urge researchers to use the approach herein to validate and create a cMetS that is specific to their study population.

Citing Articles

Continuous metabolic syndrome score in cardiovascular risk assessment in adolescents.

Kachutova I, Hirosova K, Samohyl M, Mayer Vargova K, Babjakova J, Matejakova L Cent Eur J Public Health. 2025; 32(Supplement):25-33.

PMID: 39832145 DOI: 10.21101/cejph.a7889.

Cross-sectional and longitudinal associations between serum vitamin D and continuous metabolic syndrome score among children and adolescents: roles of levels of inflammation in peripheral blood.

Li Y, Ma Z, Li Y, Xiong T, Zhang Z, Kong B Nutr Metab (Lond). 2025; 22(1):2.

PMID: 39825325 PMC: 11742777. DOI: 10.1186/s12986-024-00893-x.

Low Birth Weight and Related Metabolic Risk Factors, Cardio-Respiratory Fitness and Physical Activity in Adolescents.

Machado-Rodrigues A, Padez C, Rodrigues D, Mascarenhas L, Borges N, Maia C Children (Basel). 2025; 11(12.

PMID: 39767952 PMC: 11727343. DOI: 10.3390/children11121523.

Development, refinement, and validation of an equine musculoskeletal pain scale.

Auer U, Kelemen Z, Vogl C, von Ritgen S, Haddad R, Torres Borda L Front Pain Res (Lausanne). 2024; 4:1292299.

PMID: 38312997 PMC: 10837853. DOI: 10.3389/fpain.2023.1292299.

Socioeconomic inequalities in paediatric metabolic syndrome: mediation by parental health literacy.

Lepe A, de Kroon M, Reijneveld S, de Winter A Eur J Public Health. 2023; 33(2):179-183.

PMID: 36847730 PMC: 10066473. DOI: 10.1093/eurpub/ckad028.

References

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

Andersen L, Harro M, Sardinha L, Froberg K, Ekelund U, Brage S . Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study). Lancet. 2006; 368(9532):299-304. DOI: 10.1016/S0140-6736(06)69075-2. View

Kahn R, Buse J, Ferrannini E, Stern M . The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005; 28(9):2289-304. DOI: 10.2337/diacare.28.9.2289. View

Gungor N, Saad R, Janosky J, Arslanian S . Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr. 2004; 144(1):47-55. DOI: 10.1016/j.jpeds.2003.09.045. View

Eisenmann J, Wickel E, Welk G, Blair S . Relationship between adolescent fitness and fatness and cardiovascular disease risk factors in adulthood: the Aerobics Center Longitudinal Study (ACLS). Am Heart J. 2005; 149(1):46-53. DOI: 10.1016/j.ahj.2004.07.016. View

Zweig M, Campbell G . Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993; 39(4):561-77. View

Brage S, Wedderkopp N, Ekelund U, Franks P, Wareham N, Andersen L . Features of the metabolic syndrome are associated with objectively measured physical activity and fitness in Danish children: the European Youth Heart Study (EYHS). Diabetes Care. 2004; 27(9):2141-8. DOI: 10.2337/diacare.27.9.2141. View

Chen W, Srinivasan S, Elkasabany A, Berenson G . Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1999; 150(7):667-74. DOI: 10.1093/oxfordjournals.aje.a010069. View

Katzmarzyk P, Perusse L, Malina R, Bergeron J, Despres J, Bouchard C . Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Québec Family Study. J Clin Epidemiol. 2001; 54(2):190-5. DOI: 10.1016/s0895-4356(00)00315-2. View

10.

Lambert M, Paradis G, OLoughlin J, Delvin E, Hanley J, Levy E . Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004; 28(7):833-41. DOI: 10.1038/sj.ijo.0802694. View

11.

Moreno L, Pineda I, Rodriguez G, Fleta J, Sarria A, Bueno M . Waist circumference for the screening of the metabolic syndrome in children. Acta Paediatr. 2003; 91(12):1307-12. DOI: 10.1080/08035250216112. View

12.

Ford E . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28(7):1769-78. DOI: 10.2337/diacare.28.7.1769. View

13.

Smoak C, Burke G, Webber L, Harsha D, Srinivasan S, Berenson G . Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol. 1987; 125(3):364-72. DOI: 10.1093/oxfordjournals.aje.a114543. View

14.

Alberti K, Zimmet P, Shaw J . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-8. View

15.

Tresaco B, Bueno G, Pineda I, Moreno L, Garagorri J, Bueno M . Homeostatic model assessment (HOMA) index cut-off values to identify the metabolic syndrome in children. J Physiol Biochem. 2005; 61(2):381-8. DOI: 10.1007/BF03167055. View

16.

Eisenmann J, Welk G, Ihmels M, Dollman J . Fatness, fitness, and cardiovascular disease risk factors in children and adolescents. Med Sci Sports Exerc. 2007; 39(8):1251-6. DOI: 10.1249/MSS.0b013e318064c8b0. View

17.

Bao W, Srinivasan S, Wattigney W, Berenson G . Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med. 1994; 154(16):1842-7. View

18.

Ford E . Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28(11):2745-9. DOI: 10.2337/diacare.28.11.2745. View

19.

Kim H, Park J, Kim H, Kim D . Prevalence of the metabolic syndrome in Korean adolescents aged 12-19 years from the Korean National Health and Nutrition Examination Survey 1998 and 2001. Diabetes Res Clin Pract. 2006; 75(1):111-4. DOI: 10.1016/j.diabres.2006.04.009. View

20.

Dwyer T, Blizzard L, Venn A, Stankovich J, Ponsonby A, Morley R . Syndrome X in 8-y-old Australian children: stronger associations with current body fatness than with infant size or growth. Int J Obes Relat Metab Disord. 2002; 26(10):1301-9. DOI: 10.1038/sj.ijo.0802111. View